Thyroglobulin levels measured at the time of remnant ablation to predict response to treatment in differentiated thyroid cancer after thyroid hormone withdrawal or recombinant human TSH
Crossref DOI link: https://doi.org/10.1007/s12020-016-1104-5
Published Online: 2016-09-21
Published Print: 2017-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Pitoia, Fabian
Abelleira, Erika
Cross, Graciela
License valid from 2016-09-21